who is Dr Stephen Hahn? Stephen Michael Hahn is an American doctor who has been Commissioner for Nutrition and Drugs since December 2019. Before becoming commissioner, he was a radiotherapist-oncologist and Chief Medical Executive of the MD Anderson Cancer Center.
Dr. Stephen M. Hahn was sworn in as the 24th Commissioner of Food and Drugs on December 17, 2019. Dr. Hahn is a physician, scientist and leader in healthcare with an extensive background in patient care, academic research and executive leadership.
Dr. Hahn is a dedicated physician, trained in both medical oncology and radiotherapy. In his previous leadership positions, he has always carefully weighed executive management against the clinical time to continue serving his oncology patients, his true passion. He specializes in the treatment of both lung cancer and sarcoma.
During his oncology career, Dr. Hahn maintained a keen interest in research and wrote more than 220 peer-reviewed original research articles. His research focuses on the molecular causes of the tumor microenvial environment, in particular the study of chemical signals that go wrong (known as abnormal signal transduction pathways) and the evaluation of proton therapy as a means of improving the effectiveness of radiation therapy. His experience in the development of medical products and clinical trials includes medicines, biologic drugs, medical devices and diagnostics.
Prior to joining the FDA, Dr. Hahn was Chief Medical Executive (CME) at the University of Texas’s MD Anderson Cancer Center, an institution that cares for more than 140,000 patients a year. He has proven leadership that includes research, development, clinical trials, patient care, health system management and education. In his role as CME, he was responsible for the day-to-day management of the institution, including business, clinical and faculty matters. Under his jurisdiction was one of the largest clinical trial groups in the country. Dr. Hahn joined MD Anderson in 2015 as head of department, department president and professor of radiation oncology. Prior to joining MD Anderson, he was chairman of the Radiation Oncology Department of the Perelman School of Medicine at the University of Pennsylvania from 2005 to 2014.
Dr. Hahn earned the ranking of commander in the U.S. Public Health Service Corps on assignment at the National Institute of Health’s National Cancer Institute, where he also completed a fellowship in medical oncology and a residency in radiotherapy oncology. He also completed a residency in internal medicine at the University of California, San Francisco. He graduated from the Lewis Katz School of Medicine at Temple University in Pennsylvania and earned a bachelor’s degree in biology from Rice University in Texas.
is dr stephen hahn a trump appointee who m han urology